Ophthalmic Drops Market Intelligence Report - Global Forecast to 2027
The Global Ophthalmic Drops Market is projected to reach USD 1,615.79 million by 2027 from USD 1,075.85 million in 2021, at a CAGR 7.01% during the forecast period.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
- The Americas Ophthalmic Drops Market size was estimated at USD 386.76 million in 2021 and expected to reach USD 410.96 million in 2022, at a CAGR 6.82% to reach USD 574.67 million by 2027.
- The Asia-Pacific Ophthalmic Drops Market size was estimated at USD 272.51 million in 2021 and expected to reach USD 296.31 million in 2022, at a CAGR 7.62% to reach USD 423.59 million by 2027.
- The Europe, Middle East & Africa Ophthalmic Drops Market size was estimated at USD 416.56 million in 2021 and expected to reach USD 442.11 million in 2022, at a CAGR 6.78% to reach USD 617.52 million by 2027.
Market Segmentation & Coverage:
The report on ophthalmic drops identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.
This research report categorizes the ophthalmic drops to forecast the revenues and analyze the trends in each of the following sub-markets:
Type:
- Over-the-counter Eye Drops
- Prescription Eye Drops
Category:
- Anesthetic Drops
- Antibiotic Drops
- Dilation Drops
- Glaucoma Drops
- Steroid Drops
End User:
- Eye Clinic
- Hospitals
- Medical Institutes
- Research Organizations
Indications:
- Age-Related Macular Degeneration
- Cataract
- Glaucoma
- Inflammatory Diseases
- Refractive Disorders
Region:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- Arizona
- California
- Florida
- Illinois
- Massachusetts
- Nevada
- New Jersey
- North Carolina
- Ohio
- Pennsylvania
- Texas
- Washington
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Europe, Middle East & Africa
- France
- Germany
- Italy
- Netherlands
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- United Arab Emirates
- United Kingdom
Company Usability Profiles:
- AbbVie Inc.
- Akorn, Inc.
- Alcon Inc.
- Apotex Inc.
- Arizona
- Bausch & Lomb Incorporated
- Duopharma Biotech Berhad
- Geri-Care Pharmaceuticals Corp.
- Honeywell International Inc.
- ImprimisRx
- Johnson & Johnson Services, Inc.
- KC Pharmaceuticals, Inc.
- Massachusetts
- Nevada
- New Jersey
- North Carolina
- Novartis AG
- OCuSOFT, Inc.
- Orimed Pharma Inc.
- Pfizer, Inc.
- Preferred Pharmaceuticals Inc.
- Prestige Consumer Healthcare Inc.
- ROHTO Pharmaceutical Co., Ltd.
- Sager Pharma Kft.
- Santen Pharmaceutical Co., Ltd.
- Similasan Corporation
- Teva Pharmaceutical Industries Ltd.
- Washington
Base Year: 2021
Estimated Year: 2022
Forecast Year: 2027
Base Year Value: USD 1,075.85 million
Estimated Year Value: USD 1,149.39 million
Forecast Year Value: USD 1,615.79 million
CAGR (%): 7.01%.
Please Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Market Overview
- 4. Americas Ophthalmic Drops Market
- 4.1. Introduction
- 4.2. Argentina
- 4.3. Brazil
- 4.4. Canada
- 4.5. Mexico
- 4.6. United States
- 5. Asia-Pacific Ophthalmic Drops Market
- 5.1. Introduction
- 5.2. Australia
- 5.3. China
- 5.4. India
- 5.5. Indonesia
- 5.6. Japan
- 5.7. Malaysia
- 5.8. Philippines
- 5.9. Singapore
- 5.10. South Korea
- 5.11. Taiwan
- 5.12. Thailand
- 6. Europe, Middle East & Africa Ophthalmic Drops Market
- 6.1. Introduction
- 6.2. France
- 6.3. Germany
- 6.4. Italy
- 6.5. Netherlands
- 6.6. Qatar
- 6.7. Russia
- 6.8. Saudi Arabia
- 6.9. South Africa
- 6.10. Spain
- 6.11. United Arab Emirates
- 6.12. United Kingdom
- 7. Company Usability Profiles
- 7.1. AbbVie Inc.
- 7.2. Akorn, Inc.
- 7.3. Alcon Inc.
- 7.4. Apotex Inc.
- 7.5. Arizona
- 7.6. Bausch & Lomb Incorporated
- 7.7. Duopharma Biotech Berhad
- 7.8. Geri-Care Pharmaceuticals Corp.
- 7.9. Honeywell International Inc.
- 7.10. ImprimisRx
- 7.11. Johnson & Johnson Services, Inc.
- 7.12. KC Pharmaceuticals, Inc.
- 7.13. Massachusetts
- 7.14. Nevada
- 7.15. New Jersey
- 7.16. North Carolina
- 7.17. Novartis AG
- 7.18. OCuSOFT, Inc.
- 7.19. Orimed Pharma Inc.
- 7.20. Pfizer, Inc.
- 7.21. Preferred Pharmaceuticals Inc.
- 7.22. Prestige Consumer Healthcare Inc.
- 7.23. ROHTO Pharmaceutical Co., Ltd.
- 7.24. Sager Pharma Kft.
- 7.25. Santen Pharmaceutical Co., Ltd.
- 7.26. Similasan Corporation
- 7.27. Teva Pharmaceutical Industries Ltd.
- 7.28. Washington
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook